BRIEF-Lundbeck, Takeda receive CRL from FDA for Trintellix (vortioxetine) sNDA
* Lundbeck and Takeda receive complete response letter from the FDA for Trintellix® (vortioxetine) sNDA
March 24 Co Don Ag
* FY revenue rose by approx. 10 pct and amounted to 5.6 million euros ($6.05 million)
* FY net loss in the amount of 3.6 million euros (previous year: 2.9 million euros) Source text for Eikon: Further company coverage: ($1 = 0.9264 euros) (Gdynia Newsroom)
June 22 A U.S. judge accepted on Thursday major revisions to Arizona's death penalty procedures, such as eliminating paralytic drugs in lethal injections and giving witnesses more access to watch prisoners inside the death chamber, a lawyer for the death row inmates said.